Atorvastatin/ezetimibe 복합제 복용 후 발생한 시야결손 부작용 사례보고
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 지은희 | - |
dc.date.available | 2020-02-27T06:41:20Z | - |
dc.date.created | 2020-02-12 | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 1226-6051 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/2454 | - |
dc.description.abstract | Atorvastatin is one of the most widely prescribed medications for dyslipidemia treatment. In Korea, post combined therapy with ezetimibe, a 73-year-old woman was reported by a community pharmacy to have experienced visual field defect, which recovered after drug discontinuation. She had never experienced this symptom before, and several studies have reported an association between use of statins and visual disorders such as blurred vision, diplopia, and cataract. Blockage of cholesterol accumulation, oxidative stress, or myopathy is expected to be a cause of this symptom. Naranjo scale, Korean causality assessment algorithm (Ver.2), and World Health Organization-Uppsala Monitoring Center (WHO-UMC) criteria were the three tools used to determine causality between the visual disorder and atorvastatin. The results represent ‘probable’, ‘certain’, and ‘probable/likely’ causality, respectively. Our results, in combination with a review of literature, indicate that ocular adverse effects are highly likely related to atorvastatin | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | 한국임상약학회 | - |
dc.relation.isPartOf | 한국임상약학회지 | - |
dc.title | Atorvastatin/ezetimibe 복합제 복용 후 발생한 시야결손 부작용 사례보고 | - |
dc.title.alternative | Visual Field Defect after Taking Atorvastatin/Ezetimibe, a Case Study | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 2 | - |
dc.identifier.doi | 10.24304/kjcp.2019.29.2.133 | - |
dc.identifier.bibliographicCitation | 한국임상약학회지, v.29, no.2, pp.133 - 137 | - |
dc.identifier.kciid | ART002482731 | - |
dc.citation.endPage | 137 | - |
dc.citation.startPage | 133 | - |
dc.citation.title | 한국임상약학회지 | - |
dc.citation.volume | 29 | - |
dc.citation.number | 2 | - |
dc.contributor.affiliatedAuthor | 지은희 | - |
dc.subject.keywordAuthor | Atorvastatin | - |
dc.subject.keywordAuthor | visual field defect | - |
dc.subject.keywordAuthor | adverse drug reaction | - |
dc.subject.keywordAuthor | causality assessment | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.